Versatope Therapeutics

0 followers


Versatope Therapeutics is an infectious disease company with two lead development programs and others at the preclinical stage. Versatope delivers immunity by customizing nano-size vesicles by using synthetic biology for biopharmaceutical applications.

Industries

Employees

11-50

Links


Org chart

Christopher Locher
CEO & Co-Founder
Collapse
Kumkum Saxena
VP, Microbiology & Process Development
Alexandra Conceicao
Project Manager
Francisco Santos
Business Development Manager

Board & advisors

Matt DeLisa
Director
Dave Putnam
Director
Jim Kuo
Director
Frederick G. Hayden
Scientific Advisor
Stacey Schultz-Cherry
Scientific Advisor
David J. Topham
Scientific Advisor
Ralph A. Tripp
Scientific Advisor